NeoGenomics officer exercises RSUs, covers taxes
NeoGenomics Chief Accounting Officer Greg D. Aunan reported routine equity compensation activity involving restricted stock units and related tax withholding.
Rhea-AI Filing Summary
NeoGenomics Chief Accounting Officer Greg D. Aunan reported routine equity compensation activity involving restricted stock units and related tax withholding. On May 2, 2026, he exercised 5,372 restricted stock units into common stock and, in connection with vesting, surrendered shares to the company to satisfy tax obligations. The filings show 2,246 common shares disposed through issuer withholding across May 1 and May 2, 2026, and he now directly holds 25,153 shares of common stock. He also retains multiple unexercised stock option and RSU awards with exercise prices between $9.83 and $14.62 per share and expirations extending to 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
5,372 shares exercised/converted
Exercise
10 txns
Insider
Aunan Greg D
Role
Chief Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 5,372 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,372 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,309 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 937 | $0.00 | $0.00 |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 46,282 contracts for 35,537 underlying shares (Direct);
Common Stock — 25,153 shares (Direct);
Stock Option (Right to Buy) — 123,628 contracts (Direct)
Footnotes (12)
- F1. Shares surrendered to NeoGenomics, Inc. for retirement to satisfy tax obligations in connection with the May 1, 2026 vesting of restricted stock.
- F2. Reflects the release of restricted stock units that were previously reported on a Form 4.
- F3. Each restricted stock unit is economic equivalent of one share of NeoGenomics, Inc. common stock and is converted into common stock upon vesting.
- F4. Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
- F5. On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- F6. Once vested, the shares of common stock are not subject to expiration.
- F7. On May 1, 2023, Mr. Aunan was granted 28,662 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F8. On May 2, 2024, Mr. Aunan was granted 26,978 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F9. On February 21, 2025, Mr. Aunan was granted 31,163 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F10. On February 21, 2025, Mr. Aunan was granted 18,971 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- F11. On March 1, 2026, Mr. Aunan was granted 36,825 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F12. On March 1, 2026, Mr. Aunan was granted 22,889 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Key Figures
RSUs exercised: 5,372 shares
Shares withheld for taxes: 2,246 shares
Common shares held after transactions: 25,153 shares
+5 more
8 metrics
RSUs exercised
5,372 shares
Restricted stock units converted into common stock on May 2, 2026
Shares withheld for taxes
2,246 shares
Tax-withholding dispositions on May 1 and May 2, 2026
Common shares held after transactions
25,153 shares
Direct ownership following reported Form 4 activity
Option grant at $9.83
36,825 shares
Stock options, exercise price $9.83, expiring March 1, 2036
Option grant at $11.86
31,163 shares
Stock options, exercise price $11.86, expiring February 21, 2035
Option grant at $13.96
26,978 shares
Stock options, exercise price $13.96, expiring May 2, 2034
Option grant at $14.62
28,662 shares
Stock options, exercise price $14.62, expiring May 1, 2030
Outstanding RSUs
22,889 units
Restricted stock units granted March 1, 2026, vesting over three years
Key Terms
Restricted Stock Unit, economic equivalent, tax obligations, stock options, +1 more
5 terms
Restricted Stock Unit financial
"On March 1, 2026, Mr. Aunan was granted 22,889 restricted stock units."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
economic equivalent financial
"Each restricted stock unit is economic equivalent of one share of NeoGenomics, Inc."
tax obligations financial
"Shares surrendered to NeoGenomics, Inc. for retirement to satisfy tax obligations in connection"
stock options financial
"On May 1, 2023, Mr. Aunan was granted 28,662 stock options."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vest ratably financial
"The options vest ratably over the first three anniversary dates of the grant date."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did NeoGenomics (NEO) report for Greg D. Aunan?
NeoGenomics reported that CAO Greg D. Aunan exercised 5,372 restricted stock units into common stock and had 2,246 shares withheld to cover tax obligations. After these routine compensation-related transactions, he directly holds 25,153 shares of NeoGenomics common stock.
What equity awards in NeoGenomics (NEO) remain outstanding for Greg D. Aunan?
Greg D. Aunan retains several equity awards, including stock options and restricted stock units. Outstanding options cover 36,825 shares at $9.83, 31,163 shares at $11.86, 26,978 shares at $13.96, and 28,662 shares at $14.62, with expirations ranging from 2030 to 2036.
AI-generated analysis. How Rhea-AI works. Not financial advice.
